Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP473823.RAXiJW3tDNzee-5b0RTHG4Toep1RDLBFQXE8ZeVkepGX8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP473823.RAXiJW3tDNzee-5b0RTHG4Toep1RDLBFQXE8ZeVkepGX8130_assertion type Assertion NP473823.RAXiJW3tDNzee-5b0RTHG4Toep1RDLBFQXE8ZeVkepGX8130_head.
- NP473823.RAXiJW3tDNzee-5b0RTHG4Toep1RDLBFQXE8ZeVkepGX8130_assertion description "[Significantly raised levels of Cyr61 were associated with poor prognosis (P = 0.02), nodal involvement (P = 0.03) and metastatic disease (P = 0.016).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP473823.RAXiJW3tDNzee-5b0RTHG4Toep1RDLBFQXE8ZeVkepGX8130_provenance.
- NP473823.RAXiJW3tDNzee-5b0RTHG4Toep1RDLBFQXE8ZeVkepGX8130_assertion evidence source_evidence_literature NP473823.RAXiJW3tDNzee-5b0RTHG4Toep1RDLBFQXE8ZeVkepGX8130_provenance.
- NP473823.RAXiJW3tDNzee-5b0RTHG4Toep1RDLBFQXE8ZeVkepGX8130_assertion SIO_000772 15613452 NP473823.RAXiJW3tDNzee-5b0RTHG4Toep1RDLBFQXE8ZeVkepGX8130_provenance.
- NP473823.RAXiJW3tDNzee-5b0RTHG4Toep1RDLBFQXE8ZeVkepGX8130_assertion wasDerivedFrom befree-2016 NP473823.RAXiJW3tDNzee-5b0RTHG4Toep1RDLBFQXE8ZeVkepGX8130_provenance.
- NP473823.RAXiJW3tDNzee-5b0RTHG4Toep1RDLBFQXE8ZeVkepGX8130_assertion wasGeneratedBy ECO_0000203 NP473823.RAXiJW3tDNzee-5b0RTHG4Toep1RDLBFQXE8ZeVkepGX8130_provenance.